Encompass Health pairs FY2025 growth with a capacity-led 2026 outlook

Transcript intelligence

What changed

The call moved the focus from the prior quarter’s raised 2025 outlook to reported FY2025 performance and management’s maintained 2026 guidance. Management described continued hospital and bed expansion, while also identifying potential same-store discharge headwinds from unit closures and lease expirations.

Guidance delta

Management maintained its 2026 guidance. The supplied prior-quarter analysis concerned raised 2025 guidance, so it does not provide a like-for-like basis for quantifying a change in the current outlook.

Key takeaways

• Management characterized FY2025 revenue and EBITDA growth as double-digit, citing demand and operating leverage.
• Premium labor spend declined by more than $21 million, according to the supplied transcript analysis.
• The 2026 outlook calls for continued top-line and earnings expansion despite regulatory headwinds.
• Capacity additions and a small-format hospital model are central to the growth plan.

Management priorities

• Expand capacity through new hospitals, bed additions and the small-format hospital model.
• Manage labor costs and support clinical workforce efficiency.
• Use RCD reviews and claim processes to mitigate audit and reimbursement risk.
• Develop Palantir-enabled revenue-cycle and market analytics capabilities.